[Indication for adrenalin autoinjector after anaphylaxis].
Anaphylaxis is a potentially fatal hypersensitivity reaction, which should be treated with adrenaline. Patients at risk of recurrent anaphylaxis after the initial episode should be prescribed an adrenalin autoinjector. The patients include persons, who are allergic to insect venom, before they reach the maintenance dose of allergen-specific immunotherapy, persons with food allergy who are at risk of accidental intakes, persons with anaphylaxis induced by low-intensity physical activity, and idiopathic anaphylaxis. The recommended dose of adrenaline is 0.15 mg for children up to 20 kg and 0.30 mg for larger children and adults.
Allergiklinikken 816, Gentofte Hospital, Niels Andersens Vej 65, 2900 Hellerup, Denmark. HMAL0009@geh.regionh.dk
Hans-Jørgen
HJ
Malling
Kirsten Skamstrup
KS
Hansen
Holger
H
Mosbech
D000322:Adrenergic Agonists / Q000008:administration & dosage*; D000328:Adult; D000707:Anaphylaxis / Q000175:diagnosis / Q000188:drug therapy* / Q000517:prevention & control; D002648:Child; D011307:Drug Prescriptions; D004837:Epinephrine / Q000008:administration & dosage*; D006801:Humans; D006967:Hypersensitivity / Q000175:diagnosis / Q000188:drug therapy / Q000517:prevention & control; D007267:Injections; D010353:Patient Education as Topic; D012307:Risk Factors; D012646:Self Administration
D000322:Adrenergic Agonists; D004837:Epinephrine